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level of Go probability. Furthermore, compared to healthy 
controls, both STN-DBS and unoperated PD patients were 
more prone to making anticipatory errors; which was not 
influenced by STN stimulation. The results provide evi-
dence for ‘load-dependent’ effects of STN stimulation on 
action restraint as a function of the prepotency of the Go 
response.
Keywords Subthalamic nucleus (STN) · Deep brain 
stimulation (DBS) · Parkinson’s disease (PD) · Go/NoGo 
task · Prepotency · Load-dependent effects
Introduction
Deep brain stimulation (DBS) of the subthalamic nucleus 
(STN), (STN-DBS), is an effective treatment for the motor 
symptoms and improves quality of life in Parkinson’s 
disease (PD) (Deuschl et al. 2006; Williams et al. 2011; 
Weaver et al. 2012). STN-DBS does not affect global cog-
nitive functioning in PD (Krack et al. 2003; Follett et al. 
2010; Williams et al. 2011; Rothlind et al. 2014), and 
only isolated deficits in verbal fluency have been docu-
mented following surgery (Parsons et al. 2006). However, 
there is evidence that executive control of action becomes 
worse with STN-DBS in PD (Frank et al. 2007; Jahanshahi 
2013; Jahanshahi et al. 2015; Williams et al. 2015). This 
was shown with various tasks of executive function, such 
as the Stroop (Jahanshahi et al. 2000; Brittain et al. 2012), 
fast-paced random number generation (Thobois et al. 2007; 
Anzak et al. 2011), the stop signal task (Ray et al. 2012; 
Obeso et al. 2014), the Go/NoGo task (Hershey et al. 2004, 
2010; Kühn et al. 2004; Ballanger et al. 2009), the Simon 
interference task (Wylie et al. 2010); and on tasks requir-
ing decision-making under conflict (Frank et al. 2007; 
Abstract The evidence on the impact of subthalamic 
nucleus deep brain stimulation (STN-DBS) on action 
restraint on Go/NoGO reaction time (RT) tasks in Par-
kinson’s disease (PD) is inconsistent; with some studies 
reporting no effect and others finding that STN stimula-
tion interferes with withholding of responses and results in 
more commission errors relative to STN-DBS off. We used 
a task in which the probability of Go stimuli varied from 
100 % (simple RT task) to 80, 50 and 20 % (probabilis-
tic Go/NoGo RT task), thus altering the prepotency of the 
response and the difficulty in withholding it on NoGo tri-
als. Twenty PD patients with STN-DBS, ten unoperated PD 
patients and ten healthy controls participated in the study. 
All participants were tested twice; the order of on versus 
off stimulation for STN-DBS PD patients was counterbal-
anced. Both STN-DBS and unoperated PD patients were 
tested on medication. The results indicated that STN-DBS 
selectively decreased discriminability when the response 
was most prepotent (high—80 %, as compared to low Go 
probability trials—50 and 20 %). Movement times were 
faster with STN stimulation than with DBS off across dif-
ferent Go probability levels. There was neither an overall 
nor a selective effect of STN-DBS on RTs depending on the 
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Cavanagh et al. 2011; Coulthard et al. 2012; Zaghloul et al. 
2012).
The Go/NoGo task is an established paradigm that 
requires a motor response to one type of stimulus (Go) but 
not to another (NoGo). It is used to assess action restraint, 
i.e. the ability to withhold a response to a prepotent stimu-
lus. By altering the ratio of Go and NoGo trials, the task 
allows testing different levels of preparedness for perfor-
mance of a given motor response on ‘Go’ trials which in 
turn influences the ease/difficulty of withholding it on 
‘NoGo’ trials. The Go/NoGo task has been used to assess 
the effect of STN-DBS on inhibitory processes in a num-
ber of studies (Hershey et al. 2004, 2010; Kühn et al. 2004; 
van den Wildenberg et al. 2006; Ballanger et al. 2009), 
which are summarized in Table 1. As evident from Table 1, 
the results of these studies are inconsistent. While Her-
shey et al. (2004, 2010), as well as Ballanger et al. (2009), 
reported that STN-DBS disrupted the ability to withhold 
responses on NoGo trials, van den Wildenberg et al. (2006) 
did not find such an effect.
Hershey et al. (2004) tested whether STN-DBS in PD 
affects action restraint depending on the level of demand 
on cognitive control. They used a Go/NoGo task with 
two levels of Go probability (i.e. two levels of prepo-
tency)—83 and 50 %. The results showed that PD patients 
with STN-DBS were less able to discriminate between Go 
and NoGo trials on the 83 % Go task (when the response 
was more prepotent and with high demand on cognitive 
control) with the stimulation on. This was not observed 
for the 50 % Go task (low demand on cognitive control). 
More recently, using a paced random number generation 
(RNG) task at different rates, with faster rates requiring 
a higher level of executive control, Williams et al. (2015) 
showed that STN-DBS differentially impaired inhibi-
tion of habitual counting responses during paced RNG 
in a load-dependent fashion and only at the fastest rate of 
1 Hz. Patients could switch to more controlled RNG strat-
egies during conditions of low cognitive load at slower 
rates only when the STN stimulators were off, but when 
STN stimulation was on, they engaged in more automatic 
habitual counting under increased cognitive load at the 
fastest rate.
In the light of the results of Hershey et al. (2004) and 
Williams et al. (2015), the first aim of the study was to 
investigate the effect of STN-DBS on action restraint 
as a function of the prepotency of the Go response. We 
Table 1  Studies investigating the effect of subthalamic nucleus deep brain stimulation (STN-DBS) on Go/NoGo task performance in PD
Med. status medication status (off off medication, on on medication), N number of participants, NR not reported, STN-DBS ON STN-DBS on 
stimulation, RT reaction time, STN-DBS OFF STN-DBS off stimulation, SRT simple reaction time, CRT choice reaction time
References Med.  
status
N Type of Go/NoGo 
task
Go trials probability Commission  
error rate
Summary of results
Hershey et al. 
(2004)
Off 24 STN-DBS PD Letter/number
Non-lateralized
Response button 
press
50 and 83 % CRT NR STN stimulation sig-
nificantly reduced 
discriminability on 
high (83 %) CRT 
only
Kühn et al. (2004) Off 8 STN-DBS PD Letter/number
Lateralized
Response button 
press
80 % CRT NR No effect of stimula-
tion on either error 
rates (commission, 
omission and lat-
erality error rates) 
or RT
van den Wildenberg 
et al. (2006)
On 17 STN-DBS PD
15 Vim-DBS PD
Green/red arrow
Non-lateralized
Response button 
press
50 % CRT 0.034 (STN-DBS 
ON)
0.030 (STN-DBS 
OFF)
No effect of stimula-
tion on either false 
alarms or RT
Ballanger et al. 
(2009)
Off 7 STN-DBS PD Circle/X
Non-lateralized
Response button 
press
100 % SRT and 
60 % CRT
0.04 (STN-DBS 
OFF)
0.10 (STN-DBS 
ON)
STN stimulation sig-
nificantly reduced 
RT and increased 
the commission 
error rate
Hershey et al. 
(2010)
Off 10 STN-DBS PD Letter/number
Non-lateralized
Response button 
press
83 % CRT 0.84 (STN-DBS 
OFF)
0.82 (dorsal STN-
DBS ON)
0.78 (ventral STN-
DBS ON)
Ventral STN stimula-
tion reduced hits 
and increased 
false alarms, i.e. 
decreased discrimi-
nability, but did not 
affect RT
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compared tasks with three different levels of prepotency of 
the Go response (probabilistic Go/NoGo reaction time (RT) 
task—pGNG—with 80, 50 and 20 % Go stimuli). As out-
lined above, our prediction was that for PD patients with 
STN-DBS, stimulation would selectively impair action 
restraint and result in lower discriminability in conditions 
where the Go response is most prepotent, that is in the 
80 % Go task.
In a probabilistic choice RT saccade task, Antoniades 
et al. (2014) recently reported that, in contrast to healthy 
controls, six PD patients with STN-DBS on did not show 
increased reaction time as target probability decreased. The 
prolongation of RT with the decrease of the target prob-
ability is a normal behavioural adjustment, and this was 
observed with STN-DBS off but not on. These results were 
explained as an STN-dependent normalization of the neu-
ral representation of prior probabilities that is disrupted 
by STN-DBS. However, somewhat different results were 
obtained by Obeso et al. (2009) albeit in a single PD patient 
with a combined unilateral left subthalamotomy and pal-
lidotomy which effectively disrupted left basal ganglia out-
put. On a probabilistic Go/NoGo task, Obeso et al. (2009) 
found that relative to the ipsilesional left hand, RTs with 
the right hand contralateral to the left subthalamotomy and 
pallidotomy were significantly faster on blocks of trials 
with high (100 and 80 %), but non-significantly slower on 
blocks with lower probability (50 and 20 %) of Go stimuli. 
Therefore, the second aim of our study was to explore the 
effect of STN-DBS on changes in RT across the four levels 
of Go stimulus probability (100 %—simple RT, and 80, 50 
and 20 % pGNG).
Methods
Participants
Twenty PD patients with bilateral STN-DBS, ten unoper-
ated PD patients (PD controls) and ten age-matched healthy 
participants took part. The demographic and clinical data, 
including total L-dopa equivalence dose—LEDD, LEDD 
calculated from the L-dopa medication (L-dopa LEDD), 
LEDD calculated form dopaminergic agonists (DA-LEDD) 
(Tomlinson et al. 2010), Unified Parkinson’s disease Rating 
Scale—UPDRS (Fahn and Elton 1987) on and off stimula-
tion and group summary of the stimulation parameters, are 
presented in Table 2. The MRI-guided surgical approach 
was used to implant the DBS electrodes in STN-DBS PD 
patients (Foltynie et al. 2011). The joint ethics committee 
of the UCL Institute of Neurology and the National Hos-
pital for Neurology and Neurosurgery approved the study. 
Informed consent was obtained from all participants.
Study design
A mixed-factorial repeated-measures design was used. All 
participants performed the task twice (30 min interval). 
The order of assessment on versus off stimulation was 
Table 2  Main demographic and 
clinical data for the participants 
in the study
Mean values and standard deviations (SD, given in brackets) or median values (where appropriate) are pre-
sented
f/m number of females/males, r/l right/left, LEDD Levodopa equivalent daily dose, DA dopaminergic ago-
nists, STN subthalamic nucleus, PD Parkinson’s disease, HC healthy control participants, UPDRS Unified 
Parkinson’s Disease Rating Scale, Median frequency of STN-DBS in Hertz (Hz), Median DBS pulse width 
in microseconds (μs) and Mean DBS amplitude in volts (V)
STN-DBS PD (SD) PD controls (SD) HC (SD)
Age 56.77 (8.93) 57.70 (7.76) 54.00 (7.09)
Sex (f/m) 12/8 4/6 6/4
Handedness (r/l) 18/2 10/0 9/1
Years of education 13.18 (2.42) 13.50 (2.41) 14.20 (2.74)
Disease duration (years) 15.27 (4.34) 13.30 (5.54) –
Time since operation 3.30 (1.25) – –
LEDD (total) 575.86 (195.14) 688.31 (249.82) –
L-dopa LEDD 285.34 (161.12) 354.21 (220.54) –
DA-LEDD 275.12 (145.15) 310.12 (113.17) –
UPDRS on med/off stim. 24.09 (10.42) 21.75 (8.45) –
UPDRS on med/on stim. 12.55 (8.81) – –
Median frequency (r/l) 130/130 Hz – –
Median pulse width (r/l) 60/60 μs – –
Mean amplitude (r/l) 2.99 (0.71)/3.27 (0.76) V – –
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counterbalanced in the PD patients with STN-DBS. All PD 
patients performed the task on medication at least 30 min, 
but not longer than 90 min after taking their usual drugs.
Go/NoGo task
Participants were tested on a simple reaction time task 
(SRT, thus Go probability level of 100 %) and on a proba-
bilistic Go/NoGo reaction time task (pGNG) with three dif-
ferent levels of Go stimulus probabilities (80, 50 and 20 % 
Go trials; pGNG80, pGNG50 and pGNG20, respectively). 
These conditions were tested in four experimental blocks 
of 100 trials each (Fig. 1). An S1 auditory warning stimulus 
(800 Hz, 150 ms) was followed by a variable 500- or 1000-
ms interval. This was followed by the visual S2 stimulus—
in the SRT task always a Go stimulus (green square), in 
pGNG tasks by the same Go stimulus or a NoGo stimulus 
(red square). In all blocks, participants were instructed to 
press and hold down a home key (black button) until the 
Go signal was presented on the screen. This was the sig-
nal to release the home key, move their hand and press the 
response key (green button). In NoGo trials, participants 
were instructed to withhold any response on presentation 
of the red square and continue to hold down and press the 
home key.
Participants were instructed to always respond with 
their dominant hand. On the Go trials, the S2 disappeared 
immediately after pressing the response key. If they failed 
to move the finger from the home key (“no response”), the 
S2 disappeared after 1000 ms. On the NoGo trials, the S2 
always disappeared after 1000 ms.
Data analysis
The reaction time was defined as the interval between the 
onset of S2 and the participant lifting the index finger from 
the home key. The movement time (MT) was defined as 
the interval between the participant lifting the index finger 
from the home key and pressing the response key. While 
RT is a measure of the time needed to make a decision, 
MT is a measure of the time needed for movement execu-
tion (Jensen 1987). The distinction between RT and MT is 
important, as the compound measure (response time) that is 
usually used in reaction time tasks, takes into account both 
the RT and MT, and might not therefore reflect the speed of 
cognitive processes during task execution.
Anticipatory errors were defined as Go trials with cor-
rect responses and RTs shorter than 100 ms. Commission 
errors were trials when the participants lifted their finger 
from the home key on NoGo trials (i.e. the trials on which 
they failed to withhold a response on NoGo trials). Omis-
sion errors were Go trials on which the participant did not 
lift the finger from the home key (i.e. Go trials on which 
they failed to respond). Because the rate of omission errors 
was very low in all three groups of participants in all condi-
tions, these were excluded from further analysis.
The following relative rates were computed and com-
pared in the subsequent analysis: commission error rate 
Fig. 1  Schematic representa-
tion of the Go/NoGo task used 
in the study. As soon as the 
home key was pressed, a fixa-
tion cross was presented on the 
monitor for 1000 ms; this was 
followed by the auditory warn-
ing stimulus S1. After a variable 
interval of 500 or 1000 ms, the 
visual S2 stimulus was pre-
sented (Go—green square, or 
NoGo—red square). There were 
four different blocks with four 
levels of Go stimulus probabil-
ity levels—100 % (SRT), 80 % 
(pGNG80), 50 % (pGNG50) 
and 20 % (pGNG20). For 
details, please see “Methods” 
(color figure online)
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(CER), hit rate (HR) and anticipation error rate (AnER). 
CER was defined as the proportion of commission errors 
out of the total number of NoGo trials in a task. The HR 
was defined as the proportion of Go trials with correct 
responses out of the total number of Go trials. AnER was 
the proportion of anticipation errors out of the total number 
of Go trials.
The discriminability index (Pr), derived from signal 
detection theory (Macmillan and Creelman 2005), was cal-
culated as the difference between the hit rate and the com-
mission error rate (Pr = HR-CER). According to the signal 
detection theory, Pr is a measure of how well a person can 
discriminate between the two choices (Hershey et al. 2010) 
and it is therefore suitable to be calculated in a Go/NoGo 
task in which participants have to discriminate between the 
possibility to respond on presentation of one stimulus (Go) 
and withhold the response on presentation of another stim-
ulus (NoGo).
Statistical analysis
SPSS was used for statistical analysis of the data. The 
Shapiro–Wilk test was used to test for normality. Paramet-
ric data were analysed with repeated-measures ANOVA, 
mixed-design ANOVA and t test. If the assumption of sphe-
ricity was violated, the Greenhouse–Geisser correction was 
used. Chi-square tests were used to analyse nonparametric 
data. A probability value of p = 0.05 was set to test for sig-
nificance. Bonferroni corrections were used to control for 
multiple comparisons.
Results
There was no difference in age (F(2) = 2.78, 
p = 0.378), handedness (χ2(2) = 2.22, p = 0.329), gen-
der (χ2(2) = 1.49, p = 0.567) or years of education 
(F(2) = 0.52, p = 0.597) between the STN-DBS PD 
patients, PD controls and healthy controls. There was also 
no difference in LEDD (t(28) = −0.51, p = 0.617) or 
mean disease duration (t(28) = 1.84, p = 0.182) between 
the STN-DBS PD patients and unoperated PD controls. As 
expected, the motor part of the UPDRS was higher in PD 
patients on medication compared to STN-DBS PD on med-
ication and on stimulation, t(28) = 2.29, p = 0.035. Sim-
ilarly, the motor symptoms of the STN-DBS PD patients 
on medication and on stimulation were significantly 
improved compared to on medication and off stimulation 
(t(19) = 4.54, p = 0.001) (Table 2).
Before the mixed repeated-measures factorial model 
with between-subject factor ‘group’ (STN-DBS PD, PD 
controls and healthy controls), and within-subject fac-
tors ‘stimulation’/time of assessment (STN-DBS on vs. 
STN-DBS off or first vs. second assessment) and ‘prob-
ability level’ of Go trials (SRT, pGNG80, pGNG50 and 
pGNG20) was applied to the various measures (RT, MT, 
HR, CER, AnER and Pr), the task performance for the first 
versus second assessment was compared for the unoperated 
PD patients and healthy controls. There was no difference 
in task performance on any of the behavioural measures 
(i.e. RT, MT, HR, CER, AnER, and Pr) between the first 
and the second assessment for either the unoperated PD (all 
ps > 0.05) or the healthy controls (all p > 0.05). This means 
that there were no carry-over effects between the first and 
second assessment, and therefore, the data from the first 
and second assessment for the unoperated PD patients 
and healthy controls are equivalent and can be used inter-
changeably in comparison with the data from patients with 
STN-DBS.
STN stimulation decreased discriminability  
in the pGNG80 task only
As predicted, the discriminability index was the lowest in 
the task with the Go/NoGo task with highest Go probability 
level (80 %) (F(2,74) = 21.11, p < 0.0001) (Table 3). Even 
though the main effects of stimulation (F(1,37) = 0.98, 
p = 0.342) and group (F(1,37) = 1.30, p = 0.284) were 
not significant, the significant stimulation × probability 
interaction (F(2,74) = 3.98, p = 0.023) (Fig. 2a) indi-
cated a differential effect of stimulation depending on the 
Go probability. Indeed, while the discriminability index 
on stimulation was lower compared to off stimulation 
(F(1,37) = 3.90, p = 0.042) for the 80 % Go probability 
task (pGNG80), there was no significant difference in the 
discriminability index on versus off stimulation for the 
50 % (pGNG50) or 20 % (pGNG20) Go probability tasks 
(F(1,39) = 1.24, p = 0.272). On the pGNG80 task, 14 of 
the 20 (70 %) patients showed decreased discriminabil-
ity index on versus off STN stimulation. On the pGNG50, 
only four patients (20 %) showed decreased discriminabil-
ity index on versus off STN-DBS. For the pGNF20 task, 
seven patients (35 %) showed decreased discriminability 
on compared to off STN stimulation. There were no sig-
nificant correlations of the discriminability index on or off 
stimulation (derived for all three tasks pGNG80, pGNG50, 
pGNG20) with RT, UPDRS, LEDD, age, disease duration 
or amplitude of stimulation (all ps > 0.05).
The main effect of stimulation/time of assessment 
was not significant for either the HR (F(1,37) = 0.82, 
p = 0.370) or the CER (F(1,37) = 1.50, p = 0.228). There 
was also no significant effect of group for either the HR 
(F(1,37) = 2.43, p = 0.102) or the CER (F(1,37) = 0.96, 
p = 0.391). As expected, while the HR was the low-
est in pGNG20 (F(3,111) = 55.23, p < 0.0001), the CER 
was highest in the task with the highest probability of 
1138 Exp Brain Res (2016) 234:1133–1143
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Go responses (pGNG80) (F(2,74) = 39.95, p < 0.0001) 
(Table 3). There were no significant interaction effects for 
either HR or CER.
Both STN‑DBS and unoperated PD patients made more 
anticipation errors than healthy controls
The main effect of stimulation/time of assessment was not 
significant (F(1,37) = 1.83, p = 0.185). As expected, the 
highest AnER was associated with the highest probability 
of Go signal presentation in the SRT (F(3,111) = 10.75, 
p < 0.0001). The significant main effect of group 
(F(1,37) = 3.59, p = 0.040) indicated higher AnER for 
STN-DBS PD patients and PD controls compared to 
healthy participants (Table 3). Furthermore, the signifi-
cant group × probability interaction (F(6,111) = 2.55, 
p = 0.024) (Fig. 2b) indicated that the difference in AnER 
between groups was due to the difference in AnER for the 
SRT task (F(6,37) = 3.36, p = 0.047) mainly due to higher 
anticipatory errors for the STN-DBS PD patients than the 
healthy controls (F(1,28) = 6.61, p = 0.016) but also due 
to higher anticipations for the unoperated PD compared to 
healthy controls (F(1,18) = 4.46, p = 0.049). The differ-
ence between STN-DBS PD patients and PD controls was 
not significant (F(1,28) = 0.53, p = 0.470).
STN stimulation decreased movement time but did not 
affect reaction time
MT was shorter on stimulation than with stimulation 
off (F(1,37) = 4.01, p = 0.047) (Fig. 3b). As expected, 
MT was the shortest for healthy controls, followed by 
PD with STN-DBS and then unoperated PD patients 
(F(1,37) = 7.23, p = 0.002) (Fig. 3b, d, f). However, for 
MT, the main effect of task (F(3,111) = 1.78, p = 0.156) 
and the interaction effects were not significant.
For RTs, by contrast to MT, the main effect of stimu-
lation/time of assessment (F(1,37) = 2.56, p = 0.118) or 
group (F(1,37) = 1.64, p = 0.208) was not significant. As 
expected, across all groups, RT was shortest in the SRT task 
and longest in pGNG20 (F(3,111) = 61.10, p < 0.0001, 
Fig. 3a, c, e). None of the interaction effects were signifi-
cant (p > 0.05).
Discussion
In summary, STN stimulation had a significant effect on 
discriminability as a function of the level of prepotency of 
the response, such that the discriminability on stimulation 
was selectively lower than off stimulation on the trials with 
Table 3  Mean values and standard error of the mean (SEM) in 
brackets for the hit rate, commission error rate, anticipation error rate 
and discriminability (Pr) index for PD patients with STN-DBS ON 
and OFF, PD control patients (PD Con) and healthy controls (HC) 
1st and 2nd assessment in all tasks: simple reaction time (SRT), and 
probabilistic Go/NoGo task with three levels of Go signal probabil-
ity—pGNG80, pGNG50 and pGNG20
PD STN-DBS ON PD STN-DBS OFF PD Con 1st PD Con 2nd HC 1st HC 2nd
Hit rate
SRT 0.976 (0.010) 0.984 (0.004) 0.989 (0.006) 0.990 (0.003) 0.980 (0.001) 0.990 (0.003)
pGNG80 0.973 (0.004) 0.979 (0.005) 0.987 (0.002) 0.975 (0.005) 0.988 (0.002) 0.986 (0.005)
pGNG50 0.969 (0.006) 0.978 (0.001) 0.960 (0.002) 0.977 (0.006) 0.980 (0.003) 0.983 (0.006)
pGNG20 0.935 (0.007) 0.945 (0.003) 0.950 (0.002) 0.950 (0.002) 0.952 (0.002) 0.954 (0.002)
Commission error rate
pGNG80 0.110 (0.025) 0.078 (0.029) 0.075 (0.024) 0.118 (0.037) 0.073 (0.023) 0.105 (0.003)
pGNG50 0.037 (0.007) 0.031 (0.008) 0.039 (0.009) 0.020 (0.006) 0.018 (0.006) 0.021 (0.006)
pGNG20 0.013 (0.003) 0.012 (0.002) 0.015 (0.005) 0.020 (0.007) 0.008 (0.003) 0.007 (0.002)
Anticipation error rate
SRT 0.090 (0.017) 0.073 (0.020) 0.067 (0.002) 0.052 (0.016) 0.020 (0.006) 0.009 (0.003)
pGNG80 0.042 (0.003) 0.025 (0.009) 0.010 (0.003) 0.030 (0.009) 0.005 (0.001) 0.003 (0.001)
pGNG50 0.034 (0.004) 0.015 (0.007) 0.006 (0.001) 0.020 (0.006) 0.003 (0.001) 0.006 (0.002)
pGNG20 0.018 (0.003) 0.013 (0.003) 0.020 (0.006) 0.035 (0.011) 0.005 (0.002) 0.005 (0.002)
Discriminability (Pr)
pGNG80 0.863 (0.029) 0.901 (0.029) 0.912 (0.026) 0.857 (0.034) 0.915 (0.011) 0.881 (0.037)
pGNG50 0.932 (0.090) 0.947 (0.009) 0.921 (0.020) 0.957 (0.010) 0.962 (0.002) 0.962 (0.012)
pGNG20 0.922 (0.004) 0.933 (0.004) 0.935 (0.009) 0.930 (0.008) 0.944 (0.009) 0.947 (0.002)
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the highest Go probability of 80 % but not for pGNG50 or 
pGNG20. There was no effect of STN stimulation on RTs. 
By contrast, MTs were faster on stimulation compared to 
off stimulation across all tasks (SRT, pGNG80, pGNG50 
and pGNG20). In addition, there was a significant effect 
of group, but not stimulation, on the anticipatory error rate, 
such that both STN-DBS and unoperated PD patients were 
more prone to make anticipations as compared to healthy 
controls.
STN‑DBS disrupts action restraint for the most 
prepotent responses
Performance on the probabilistic GoNoGo RT tasks 
depends on a balance between the preparedness to respond 
on Go trials and the success in withholding responses on 
NoGo trials (Obeso et al. 2009). The inhibition of a pre-
pared response is most difficult and demanding when 
the response is more prepotent, that is, in blocks with a 
higher percentage of Go trials. We therefore predicted that 
STN-DBS would interfere with action restraint where the 
Go response was most prepotent, that is on the pGNG80 
blocks.
Indeed, the significant stimulation × probability inter-
action indicated an effect of STN stimulation on discrimi-
nability depending on Go probability: PD patients with 
STN-DBS on stimulation showed the lowest discrimina-
bility index in the condition with the highest proportion of 
Go trials (80 %) compared to lower Go probability (50 and 
20 %) on the pGNG. As evident from Table 3, this pattern 
of results seems to be driven primarily by the stimulation-
induced increase in commission errors on NoGo trials 
since the hit rates do not differ between the two stimulation 
conditions. Therefore, this suggests that the lowered dis-
criminability is due to increased commission errors, i.e. an 
inability to withhold responses on the most prepotent 80 % 
Go/NoGo condition. This supports our first hypothesis and 
is in line with the findings of Hershey et al. (2004) who 
found a decrease of discriminability on Go/NoGo tasks 
with high (83 % Go) but not low (50 %) Go probability. 
The finding that the discriminability with STN stimulation 
was lowest on the block with the highest Go probability 
means that STN-DBS interfered with action restraint on tri-
als when the Go response was most prepotent. Therefore, 
the results of our study and those of Hershey et al. (2004) 
and Williams et al. (2015) indicate that the effect of STN-
DBS on performance of attention-demanding tasks requir-
ing the ability to withhold prepotent responses is load-
dependent. For example, Williams et al. (2015) found that 
STN-DBS differentially impaired inhibition of habitual 
counting responses (count score 1) during paced RNG in a 
load-dependent fashion only at the fastest rate of 1 Hz, but 
not at the slower rates of 0.33 and 0.5 Hz.
Kühn et al. (2004) recorded local field potentials from 
the STN in the immediate post-operative phase while 
PD patients performed a Go/NoGo task. They found that 
whereas on Go trials, prior to movement, there was a beta 
desynchronization followed by a late post-movement beta 
synchronization, on NoGo trials the beta desynchronization 
was prematurely terminated and immediately reversed into 
beta synchronization. This was interpreted as indicating 
that beta activity recorded from the STN may be a marker 
of initiation (or withholding) of movement programming. 
The imaging study of Ballanger et al. (2009) highlighted 
the brain networks that were modulated by STN-DBS 
in PD during performance of a Go/NoGo task. Relative 
to DBS off, STN stimulation was associated with a sig-
nificant reduction of activation in the pre-SMA and dor-
sal and ventral premotor cortex, dorsal anterior cingulate 
Fig. 2  Significant interaction effects for the discriminability index 
(Pr) (a) and anticipatory error rate (AnER) (b) for PD patients with 
STN-DBS (PD STN-DBS), unoperated PD (PD Con) and healthy 
controls (Con) for four different levels of Go stimulus probability 
levels—100 % (SRT), 80 % (pGNG80), 50 % (pGNG50) and 20 % 
(pGNG20). DBS ON on stimulation, DBS OFF off stimulation. The 
asterisk (*) indicates significant difference (p < 0.05)
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cortex, primary motor cortex and the inferior frontal cor-
tex, together with an increased activation in the subgenual 
anterior cingulate cortex. These results were interpreted as 
STN-DBS modulating networks associated with proactive 
and reactive inhibition.
In the present study, STN stimulation decreased the HR 
and increased the CER, but these effects were not signifi-
cant. There was, however, a significant main effect of prob-
ability on both of these measures. HR was lowest on the tri-
als with the lowest level of response prepotency—pGNG20 
task, whereas CER was highest during the highest level of 
response prepotency—pGNG80 task.
STN‑DBS did not disrupt slowing to less probable 
stimuli
We did not replicate the finding of Antoniades et al. (2014) 
that STN-DBS disrupted the slowing of RTs to less prob-
able stimuli. Antoniades et al. (2014) used a probabilistic 
choice RT saccade task (10, 25, 50, 75 and 90 %) to test the 
effect of STN-DBS on normalization of prior probabilities. 
They found that when the stimulator was switched off, RTs 
were shorter for more probable and longer for less prob-
able targets, which is the usual pattern of RT changes as a 
function of target probability observed in healthy controls 
Fig. 3  Reaction times (RT) 
and movement times (MT) for 
the correct Go responses for 
patients with STN-DBS (PD 
STN-DBS) (a, b), PD controls 
(c, d) and healthy controls 
(e, f) for four different levels 
of Go stimulus probability 
levels—100 % (SRT), 80 % 
(pGNG80), 50 % (pGNG50) 
and 20 % (pGNG20). DBS ON 
on stimulation, DBS OFF off 
stimulation, 1st first assessment, 
2nd second assessment. The 
asterisk (*) indicates significant 
difference (p < 0.05)
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as well. In their study, when the STN stimulators were 
switched on, RTs were still shorter for more probable trials, 
but they did not increase, as the target became less likely. 
This was interpreted as indicating that stimulation dis-
rupted the effect of STN on normalization of the neuronal 
representations of prior probabilities. The fact that Antonia-
des et al. (2014) tested the effect of STN-DBS on a choice 
RT saccade task rather than a manual Go/NoGo task could 
partly account for the discrepancy in findings with our 
study. The basal–ganglia–thalamo–cortical loops (DeLong 
1990; DeLong and Wichmann 2010) are largely segregated, 
and it is possible that it is easier to observe the effect of nor-
malization of RTs related to prepotency in a saccadic task, 
involving the ‘oculomotor’ circuit, than in a Go/NoGo task 
with manual responses mediated by the ‘motor’ circuit. In 
our study, we recorded both RT and MTs in a probabilistic 
Go/NoGo RT task as they reflect different processes. While 
RTs increase proportionally to the amount of information 
contained in presented stimuli, MT is relatively unaffected 
by it (Jensen 1987). Therefore, RT corresponds to the 
time required to make a decision, whereas MT reflects the 
time needed to execute the response. Indeed, the distinc-
tion between RT and MT is one of the advantages of our 
study. As expected, for all groups the RT was shortest on 
the trials with the highest level of preparedness to respond, 
that is during the SRT trials (Go probability of 100 %) and 
RTs were longest for the lowest probability of Go stimuli 
(pGNG20). In contrast, the manipulation of Go probabil-
ity did not have any effect on MT, since MT is simply the 
time taken for execution of the response. As expected, in 
our study, MT was the shortest for healthy participants, 
and importantly, it was shorter for STN-DBS patients with 
stimulation on than off. The shorter MT on versus off stim-
ulation, which reflects the improved motor abilities of the 
STN-DBS patients as a result of the stimulation, was also 
supported by the lower motor UPDRS score for STN-DBS 
PD patients on than off stimulation. It is possible that in 
some of the studies that do not distinguish between RT and 
MT, the effect of STN-DBS on RT (Hershey et al. 2004; 
Ballanger et al. 2009) is at least partially reflecting move-
ment execution time (MT). Our results of the effect of 
STN-DBS on RTs as a function of the probability of the Go 
stimuli is roughly consistent with the performance of a PD 
patient with a combined subthalamotomy and pallidotomy 
on the same task as reported by Obeso et al. (2009).
PD patients made more anticipatory errors 
than healthy controls
Compared to healthy controls, PD patients, both oper-
ated and unoperated patients, were more prone to making 
anticipatory errors on the trials with the highest level of pre-
paredness, that is on the SRT task (100 % Go probability). 
Even though the anticipatory error rate was higher for 
patients with STN-DBS compared to the unoperated PD 
patients for all blocks except for the lowest Go probability 
level (pGNG20), this difference was not significant. The 
increased anticipatory errors for the unoperated patients may 
reflect executive dysfunction which can be present from the 
early stages of PD (Dirnberger and Jahanshahi 2013). The 
increased rate of anticipatory errors in PD may partly relate 
to the fact that both control PD patients and patients with 
STN-DBS were tested on medication. Dopaminergic medi-
cations are known to adversely affect performance on some 
tasks in PD (Gotham et al. 1986; Cools 2006). For exam-
ple, in a recent study Huang et al. (2015) found an increase 
of the error rate in PD patients on dopaminergic medica-
tion compared to the off medication state during a percep-
tual decision-making task. Moreover, as assessed by the 
drift diffusion model (Ratcliff and McKoon 2008), which 
allows for more detailed description of processing in a RT 
task beyond the accuracy and RT measures by calculating 
different parameters, such as the boundary separation (the 
amount of information to reach a decision) and drift rate 
(speed of information accumulation), the increased error 
rate in PD patients on medication was a result of a change 
of the quality of sensory information processing induced 
by dopaminergic medication that was reflected in a lower 
drift rate when patients were test on medication relative 
to the ‘off’ state. The fact that we did not test patients off 
medication is potentially one of the limitations of the pre-
sent study. This was primarily because the main objective 
of this study was to explore the effect of STN-DBS, not the 
effect of medication, on the probabilistic Go/NoGo task. 
In addition, we did not test the patients off medication and 
off stimulation. However, testing PD patients off medica-
tion and off stimulation is much more challenging for the 
patients. However, the fact that we found an effect of STN 
stimulation on discriminability argues against interference 
of the on medication state of the patients with STN-DBS 
during Go/NoGo task execution. Another possible limita-
tion of the study would be that we did not take into account 
the position of the electrodes. Nevertheless, this issue has 
already been addressed before in a study by Hershey et al. 
(2010), who found that even though stimulation of both the 
ventral and dorsal STN improved motor symptoms in PD, 
the performance of Go/NoGo task was disrupted by stimu-
lation of the ventral STN only, resulting in lower hits and 
higher commission errors. On the positive side, relative to 
most previous studies, which have small samples, in this 
study we assessed a larger number of patients and compared 
the performance of STN-DBS PD patients and age-matched 
unoperated PD patients and healthy participants. We also 
measured both RTs and MTs and showed that while MTs 
were shortened with STN-DBS, there was no effect of the 
STN stimulation on RT.
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Conclusions
STN-DBS selectively decreased discriminability on tasks 
with high (80 %), but not low probability of Go stimuli 
(50 and 20 %). Furthermore, while there was an effect of 
stimulation on MT across different probabilities of Go 
stimuli, there was no effect of STN stimulation on RT. 
Compared to healthy controls, both STN-DBS and unoper-
ated PD patients made more anticipatory errors; this was 
not affected by stimulation. We provide evidence for ‘load-
dependent’ effects of STN stimulation as a function of the 
prepotency of the Go response.
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